Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation.
Tachibana T, Najima Y, Akahoshi Y, Hirabayashi S, Harada K, Doki N, Uchida N, Fukuda T, Sawa M, Ogata M, Takada S, Tanaka M, Matsuhashi Y, Tanaka J, Onizuka M, Ichinohe T, Atsuta Y, Kako S; Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Tachibana T, et al. Among authors: hirabayashi s. Ann Hematol. 2020 Oct;99(10):2393-2404. doi: 10.1007/s00277-020-04212-1. Epub 2020 Aug 15. Ann Hematol. 2020. PMID: 32803312
CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.
Matsui H, Shirakawa K, Konishi Y, Hirabayashi S, Sarca AD, Fukuda H, Nomura R, Stanford E, Horisawa Y, Kazuma Y, Matsumoto T, Yamazaki H, Murakawa Y, Battivelli E, Verdin E, Koyanagi Y, Takaori-Kondo A. Matsui H, et al. Among authors: hirabayashi s. J Virol. 2021 Mar 25;95(8):e02394-20. doi: 10.1128/JVI.02394-20. Epub 2021 Jan 27. J Virol. 2021. PMID: 33504604 Free PMC article.
APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
Hirabayashi S, Shirakawa K, Horisawa Y, Matsumoto T, Matsui H, Yamazaki H, Sarca AD, Kazuma Y, Nomura R, Konishi Y, Takeuchi S, Stanford E, Kawaji H, Murakawa Y, Takaori-Kondo A. Hirabayashi S, et al. Biochem Biophys Res Commun. 2021 Mar 26;546:178-184. doi: 10.1016/j.bbrc.2021.02.008. Epub 2021 Feb 13. Biochem Biophys Res Commun. 2021. PMID: 33592502 Free article.
Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status.
Shimomura Y, Hara M, Hirabayashi S, Kondo T, Mizuno S, Uchida N, Mukae J, Kawakita T, Fukuda T, Kanda Y, Ota S, Ozawa Y, Eto T, Maruyama Y, Tanaka M, Nakano N, Kimura T, Ichinohe T, Atsuta Y, Yanada M. Shimomura Y, et al. Among authors: hirabayashi s. Bone Marrow Transplant. 2021 Sep;56(9):2302-2304. doi: 10.1038/s41409-021-01380-0. Epub 2021 Jun 21. Bone Marrow Transplant. 2021. PMID: 34155357 No abstract available.
Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type.
Konuma T, Kanda J, Kuwatsuka Y, Yanada M, Kondo T, Hirabayashi S, Kako S, Akahoshi Y, Uchida N, Doki N, Ozawa Y, Tanaka M, Eto T, Sawa M, Yoshioka S, Kimura T, Kanda Y, Fukuda T, Atsuta Y, Kimura F. Konuma T, et al. Among authors: hirabayashi s. Clin Cancer Res. 2021 Sep 1;27(17):4825-4835. doi: 10.1158/1078-0432.CCR-20-4856. Epub 2021 Jun 22. Clin Cancer Res. 2021. PMID: 34158357
394 results